Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Real World Evidence, a substitute for pharmacovigilance reporting and safety documentation
- In: F11 - The value of real world evidence - will availability of data lead to a paradigm change? on Tuesday, 3 September 2013, 09.00-12.00
- At: Dublin (Ireland) (2013)
- Type: Presentation
- By: NOREN, Niklas (Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring , Sweden) The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023